Citadel Embolization Device Study

B
Bradley N. Bohnstedt, MD

Primary Investigator

Enrolling By Invitation
18 years - 80 years
All
Phase N/A
150 participants needed
1 Location

Brief description of study

The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.

Detailed description of study

In this study, use of the Citadel Embolization Device will be limited to a population ofwith unruptured or ruptured wide-neck aneurysms who meet all study eligibility. The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Unruptured Wide-neck Aneurysms
  • Age: 18 years - 80 years
  • Gender: All

Inclusion Criteria:
  1. Has a single, unruptured or ruptured target intracranial aneurysm that is suitable fordovascular treatment.
Exclusion Criteria:
1.Target aneurysm has been previously treated

Updated on 01 Aug 2024. Study ID: CDM10001448
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

This study is accepting only persons who receive care at a certain clinic or doctor or who are part of an invited group. Questions about this study can be directed to the study team listed in the description or contact your doctor to see if you are eligible.

Accepting Referrals by Invitation Only